Nilay Shah, MD
Dr. Shah joins Dr. Mark Ranalli’s research team in the Division of Hematology/Oncology & BMT. Dr. Shah received both his undergraduate degree in biology and his MD from Northwestern University in Chicago. While there, he spent some time in Dr. Sue Cohn’s lab, which sparked his long-time interest in neuroblastoma. He then did his pediatric residency at the Children’s Hospital of Wisconsin and his subspecialty training in pediatric hematology/oncology at the combined Johns Hopkins University / National Institutes of Health program. There he developed projects on the roles of homeobox genes and large intervening non-coding RNAs in cancer. Most recently he was a research instructor in the Lombardi Comprehensive Cancer Center at Georgetown University, working under the mentorship of Dr. Jeff Toretsky. Dr. Shah joins The Research Institute as a physician-scientist with a laboratory and office on the 4th floor of RBII. His research will focus on neuroblastoma biology and he will be a member of Dr. Ranalli’s embryonal tumor program.
Ruonging Wang, PhD
Dr. Wang joins Dr. Peter Houghton’s Lab. Dr. Wang received his Bachelor of Science degree in medicinal chemistry from China Pharmaceutical University and Master of Science degree in biochemistry from Nanjing Medical University. He then completed his doctorate at the University of Texas MD Anderson Cancer Center, studying cell cycle checkpoints. He was a postdoctoral fellow for the past five years at St. Jude Children’s Research Hospital working with Douglas Green and publishing extensively on T cells. His research focuses on the dynamic interplay between nutrients-mediated metabolic pathways and cell signaling cascades, and the impact of this interplay on cell fate decision in immunity and cancer. His office and lab will be on the 5th floor of RBII.